Gastrointestinal events after opioid treatment in nonmalignant pain: Correlates of occurrence and impact on health-related quality of life

Journal of Opioid Management

Volumn 9, Issue 3, 2013, Pages 205-216

  Lapane, Kate L ^a   Quilliam, Brian J ^b   Benson, Carmela ^c   Chow, Wing ^c   Kim, Myoung S ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Ambulatory care; Gastrointestinal adverse events; Opioids; Pain; Registry

Indexed keywords

OPIATE; OXYCODONE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CHRONIC PAIN; CONSTIPATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL COMPONENT SCALE; MODIFIED MEMORIAL SYMPTOM ASSESSMENT SCALE; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA; OBSERVATIONAL STUDY; PHYSICAL HEALTH COMPONENT SCALE; PRESCRIPTION; PROSPECTIVE STUDY; QUALITY OF LIFE; SHORT FORM 12; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CONSTIPATION; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; NAUSEA; PAIN; QUALITY OF LIFE; VOMITING;

EID: 84882380262     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2013.0161     Document Type: Article

References (35)

1. National Center for Health Statistics: Health, United States, 2006. Hyattsville, MD: National Center for Health Statistics, 2006.
2. Sawyer P, Bodner EV, Ritchie CS, et al.: Pain and pain medication use in community-dwelling older adults. Am J Geriatr Pharmacotherapy. 2006; 4: 316-324.
3. Gaskin DJ, Richard P. The economic costs of pain in the United States./Pain. 2012; 13(8): 715-724.
4. The joint Commission: Facts about pain management, 2011. Available at http://www.jointcommission.org/pain-management/. Accessed 12 March, 2011.
5. Lippe PM: The decade of pain control and research. Pain Med. 2000; 1:286.
6. S. 2607-106th Congress. Pain Relief Promotion Act of2000, 2000.
7. Moskovits BL, Benson CJ, Patel AA, et al.: Analgesic treatment for moderate to severe acute pain in the US: Patients' perspectives in the Physicians Partnering Again Pain (P3) Survey. J Opioid Manag. 2011; 7: 277-286.
8. Apfelbaum JL, Chen C, Mehta SS, et al.: Postoperative pain experience: Results from a national survey suggest postoperative pain continues to be undermanaged. AnesthAnalg. 2003; 97: 534-540.
9. Chou R, Fanciullo GJ, Fine PG, et al.: Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009; 10: 113-1301.
10. American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons: Pharmacological management of persistent pain in older persons, J Am Geriatr Soc. 2009; 57:1331-1346.
11. Noble M, Tregear SJ, Treadwell JR, et al.: Long-term opioid therapy for chronic noncancer pain: A systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage. 2008; 35(2): 214-228.
12. Kalso E, Edwards JA, Moore RA, et al.: Opioids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain. 2004; 112: 372-380.
13. Werawatganon T, Charuluxanun S: Patient controlled intravenous opioid analgesia versus continuous epidural analgesia for pain after intra-abdominal surgery. Cochrane Database Syst Rev. 2005; (1): CD004088.
14. Kim M, Benson C, Chow W, et al.: Design of the Oxycodone Users Registry (OUR): A prospective, multicenter registry of patients with non-malignant pain. J Opioid Manag. 2013; 9:189-204.
15. Kim M, Benson C, Chow W, et al.: Design of the Oxycodone Users Registry (OUR): A prospective, multicenter registry of patients with non-malignant pain. J Pain. 2010; 11(4)Suppl 1: S49 [abstract 293].
16. IOM (Institute of Medicine): Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: The National Academies Press, 2011.
17. Portenoy RK, Thaler HT, Kornblith AB, et al.: The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994; 30A: 1326-1336.
18. Apelbaum JL, Gan TJ, Zhao S, et al.: Reliability and validity of the perioperative opioid-related symptom distress scale. Anesth Analg. 2004; 99: 699-709.
19. Shalev V, Chodick G, Heymann AD, et al.: Gender differences in healthcare utilization and medical indicators among patients with diabetes. Public Health. 2005; 119: 45-49.
20. Bertakis KD, Azari R, Helms LJ, et al.: Gender differences in the utilization of health care services. J Fam Pract 2000; 49:147-152.
21. Owens GM: Gender differences in health care expenditures, resource utilization, and quality of care. J Managed Care Pharm. 2008; 14: 2-6.
22. Field TS, Gurwitz JH, Harrold LR, et al.: Risk factors for adverse drug events among older adults in the ambulatory set-Wng. J Am Geriatr Soc. 2004; 52: 1349-1354.
23. Mitchell SJ, Hilmer SN, McLachlan AJ: Clinical pharmacology of analgesics in old age and frailty. Rev Clin Gerontol. 2009; 19: 103-118.
24. Dorr DA, Jones SS, Burns L, et al.: Use of health-related, quality-of-life metrics to predict mortality and hospitalizations in community-dwelling seniors.J Am Geriatr Soc. 2006; 54(4): 667-673.
25. Singh JA, Nelson DB, Fink HA, et al: Health-related quality of life predicts future health care utilization and mortality in veterans with self-reported physiciandiagnosed arthritis: The veterans arthritis quality of life study. Semin Arthritis Rheum. 2005; 34(5): 755-765.
26. Ware J Jr, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34: 220-233.
27. Ware JE Jr, Kosinski M, Turner-Bowker D, et al.: User's Manual for the SF-12v2™ Health Survey with a Supplement DocumentingSF-l2.5 R-Health Survey. Lincoln, RI: QualityMetric Incorporated, 2002.
28. Kutner MH, Nachtsheim CJ, Neter J, et al.: Applied Linear Statistical Models, 5th ed. New York, NY: McGraw-Hill Irwin, 2005.
29. Iyer S, Davis KL, Candrilli S: Opioid use patterns and health care resource utilization in patients prescribed opioid therapy with and without constipation. Manag Care. 2010; 19(3): 44-51.
30. Kwong JW, Diels J, Kavanagh S: Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain. Ann Pharmacother. 2010; 44: 630-640.
31. Cook SF, Lanza L, Zhou X, et al.: Gastrointestinal adverse effects in chronic opioid users: Results from a population-based survey. Aliment Pharmacol Ther. 2008; 27: 1224-1232.
32. Bliven BD, Kaufman SE, Spertus JA: Electronic collection of health-related quality of life data: Validity, time benefits, and patient preference. Qual Life Res. 2001; 10(1): 15-22.
33. Bell T, Annunziata K, Leslie JB: Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: Findings from the National Health and Wellness Survey. J Opioid Manag. 2009; 5(3):137-144.
34. Annemans L: Pharmacoeconomic iinpact of adverse events of long-term opioid treatment for the management of persistent pain. Clin Drug Investig. 2011; 31(2): 73-86.
35. Anastassopoulos KP, Chow W, Ackerman SJ, et al.: Oxycodone-related side effects: Impact on degree of bother, adherence, pain relief, satisfaction, and quality of life. J Opioid Manag. 2011;7:203-215.